Key Takeaway: Multiple Myeloma (MM) is a condition characterized by uncontrolled growth of plasma cells in the bone marrow. This abnormal proliferation leads to the crowding out of healthy blood cells and the production of harmful proteins affecting bones, kidneys, and the immune system. Common symptoms include bone pain, fatigue, and frequent infections.
Price reaction · baseline $1.53 (2025-10-21 close) · hit pre-market · 3 other FATE headline(s) in the window, move may be shared
day 0 close · peak
-2.6%
Market Sentiment Analysis
Full Press Release Details
Multiple Myeloma is diagnosed when a patient’s plasma cells grow uncontrolled. Plasma cells are a type of blood cell found in bone marrow that normally help fight infections by making antibodies. When there are too many plasma cells, they crowd out healthy blood cells and make abnormal proteins that impact bones, kidneys, and the immune system. Symptoms include bone pain, fatigue, and frequent infections.
Bone
Too many plasma cells can make abnormal proteins that impact the bones
Kidneys
Too many plasma cells can make abnormal proteins that impact the kidneys
Immune System
Too many plasma cells can make abnormal proteins that impact the immune system
Frequently Asked Questions
What is Multiple Myeloma?
Multiple Myeloma is a cancer that occurs when plasma cells grow uncontrollably in the bone marrow.
What are the symptoms of Multiple Myeloma?
Symptoms include bone pain, fatigue, and frequent infections due to the impact on blood cells.
How does Multiple Myeloma affect the body?
It affects bones, kidneys, and the immune system by producing abnormal proteins.
What causes Multiple Myeloma?
It is caused by the uncontrolled growth of plasma cells in the bone marrow.